The efficacy of cidofovir treatment of mice infected with ectromelia (mousepox) virus encoding interleukin-4
Improved vaccines and therapies for virulent poxvirus infection are required, particularly in the light of recent threats of bioterrorism. Cidofovir (HPMPC) is an acyclic nucleoside analog with proven efficacy against poxviruses. Here, we evaluated HPMPC
|Collections||ANU Research Publications|
|01_Robbins_The_efficacy_of_cidofovir_2005.pdf||143.41 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.